The Pharmaceutical Society of Korea

Molecular pharmacology of ABHD5, a druggable master regulator of lipid metabolism

Navigating the AI revolution in academia: Strategies for writing and research in the ChatGPT era

Targeting netrin-1 in cancer: from mechanisms to phase II clinical trial

Targeting late cell cycle checkpoints to circumvent chemotherapy resistance in metastatic colorectal cancer.

FOXO-1-dependent transcription network is a therapeutic target of mantle cell lymphoma

Identification of tumor metastatic microenvironments using prostate organoid models

New molecular regulators and their potential roles in cellular senescence

The application of in vivo imaging systems in toxicology research

Novel toxicity mechanisms of organotins

Surveillance on metabolic dysfunction-mediated disorders

GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans

The recent trends in obesity drug development, and Hanmi's differentiation strategy

Intestinal FXR agonism: Current understanding for MASH treatment

Calibration of innate immunity via gut-derived factors to establish cold-inflamed liver

Key note speech on biopharmaceutical research and training

Specialised training programs to build capacity and capabilities in the mRNA workforce: Monash University, Australia

Navigating ATMP/CGT barriers and bridging the skills gap

Role of regulatory science-based global vaccine training at K-VCAST

Splicing ribozyme-based RNA editing therapeutics

Targeted demethylation of cathepsin D via epigenome editing rescues pathology in Alzheimer’s disease mouse model

제주 번행초를 활용한 구강건조증 (Xerostomia) 치료제 개발

Modulation of Metabolic and Inflammatory Pathways by IFNgamma: The role of GLUT3 in HaCaT Cells and Psoriasis Pathogenesis

Association between Insulin Resistance and CKD progression in Type 2 Diabetes Patients with Initial Low CKD Risk: A 4-Year Follow-up Study Using KoGES Data

Educational Pharmacokinetic Modeling and Simulation using Python and Generative AI

Optimizing Outcomes: Bevacizumab with Carboplatin and Paclitaxel in 5110 Ovarian Cancer Patients - A Systematic Review and Meta-Analysis

The Correlation between Cadherin Arrangement and Intermediate of Cholesterol Synthesis in Alzheimer's Model

Antipruritic effect of ursolic acid through MRGPRX2/MrgprB2-dependent inhibition of mast cell degranulation and reduced TSLP production

Cutting-edge liver organoids for the assessment of toxicity and drug metabolism

Current strategies for brain organoid-based drug screening platform with bioconvergence methods

Exploring novel bisretinoids in human retinal pigment epithelium

Determination of the intact redox status of Coenzyme Q10

The dynamic landscape of membrane glycostructures in molecular recognition

Regulation of interleukin-17, a cytokine with diverse functions

Chemical biology of self-assembly

Introduction to desorption electrospray ionization (DESI), an atmospheric pressure ionization technique for MS Imaging, and its applications

Genome editing-based drug development for treating genetic disorders

Dissecting Human Diseases with Genetics and Pluripotent Stem cells

Dynamic adaptation of regulatory T cells upon environmental stimuli

From genomics to therapies: translating innovative treatments targeting long non-coding RNAs for cardiac fibrosis

Exploring the potential impact of probiotic use on cancer treatment

The current status and future of medical food

Clinical application and management of medical foods

Clinical trials of functional food

Understanding gut microbiome-mediated medical food effects

Cancer patient prognosis prediction research based on federated learning of electronic medical record data

Development of oral controlled-release formulation using osmotic drug delivery system

Formulation technologies for inhaled drug delivery

Introduction of IMD(Incrementally Modified Drug) formulation development

Stimuli-activated formulation for innovative drug development

Skin barrier formation by ceramides and related skin diseases

Intracellular calcium-phosphoinositide signaling and Insulin resistance: Molecular mechanisms and therapeutic targets

Regulatory roles of adipose tissue macrophages in metabolic homeostasis and inflammation

Chemometrics-based integrative approaches to discover bioactive natural products

Drug development for pediatric heart failure: Neonatal-specific functions of cardiac angiotensin receptor

Research and development of novel brain stimulation technologies for controlling neurological and psychiatric disorders

Muscle-organ crosstalk: from understanding diseases to therapeutic candidate discovery

Harnessing nanotechnologies for biosensing and CRISPR gene editing in precision medicine

Practical applications of nuclear medicine and molecular imaging in new drug development: case studies and practical experiences

The role of PET imaging in the development of biomolecules based new drug candidates: Case studies and practical experiences

Radiopharmaceuticals for boron neutron capture therapy

Radioactivity and human body

Simple Alzheimer’s Disease Model Using Cerebral Organoid Technology

Deciphering the crosstalk of metareceptome in cancer and beyond

Regulation of neurodegenerative signaling pathways induced by protein aggregates

IL-33 plays a crucial role in the function of secondary effector Th2 cells for developing steroid resistant-allergic asthma

Muscle-specific RNA controls the developmental transcriptome via heterochromatin organization

Nucleoside analogues as potent antiviral agents: Development and therapeutic potential

Strategies and applications in developing TLR7/8 agonists for innate immune modulation

Structure-based design and synthesis of novel O-GlcNAcase inhibitors for Alzheimer’s disease

Structural modification of some natural products for hit-to-lead optimization

AT-211: CLDN18.2-targeting ADC with a superior therapeutic index

Discovery of ROTACs and bridged PROTACs; Turning undruggable targets Into druggable targets

The Past, present, and future of chemical proteomics using sulfonyl triazole exchange chemistry(SuTEx) for drug discovery

The construction of DNA-encoded library for drug discovery

Functional genomics approach for discovery of novel therapeutic strategies against intractable cancer

Digital transformation-based Pharma 4.0 trend and advanced use cases of AI in pharmaceutical manufacturing

Artificial intelligence for drug discovery - strategies and applications

Exploring the landscape of potential small and drug substance related nitrosamines in pharmaceuticals leveraging in-silico tools.

Regulatory landscape for the use of AI in drug development

The founding and 10-year activities of the Pharmacy History Division, the Pharmaceutical Society of Korea

10 Years of the Pharmacy History Division: Achievements and future prospects

100 Years of Korean Pharmaceutical Industry - A Look at the Past 70 Years and the Next 30 Years by Yakup Newspaper (Yakup Shinmoon)

Past and present of endowed chair in pharmacy school at the University of Tokyo

Polymeric micelles: Drug-dependent morphological transitions and their impact on pharmacological efficacy

Shaping the tumor immune microenvironment through targeted anticoagulant delivery

Oral delivery of GLP-1A utilizing ASBT-mediated endocytosis

Antibacterial strategies targeting iron regulation

Development of Therapeutically Active Nucleoside Analogs 

A New Paradigm in Molecular Basis of Breast Cancer Progression 

Global Innovative New Drug Development Strategy with New Modalities

Preclinical development of an anti-neuroinflammatory drug for the treatment of Parkinson’s disease

Nonclinical development of CTN001 for treating patients with breast cancer and gastric cancer

Clinical Trial for Safety Evaluation of CAR-T Therapy YYB-103 Targeting Novel Tumor Antigen IL13Ra2

Using real-world data and machine learning for precision overdose prevention in US: the current state and challenges

Opioids and Hepatitis C Virus in the U.S.: Understanding the Impact and Path Forward

Opioids and hepatitis C virus in the U.S.: Understanding the impact and path forward

Group-based trajectory of opioid use in Korea, and cross-continental comparison using WHO-UMC vigibase data

Narcotics safety management by NIMS(Narcotics Information Management System)

Novel Long-Acting Peptide Microspheres with Reduced Injection Site Reactions and High Bioavailability

Degradation of Polo-like kinase 1 by the N-degron pathway PROTAC regulates tumor growth in non-small cell lung cancer

Peptide drug development: The role of USP standards in quality control

Quality considerations for GLP-1 based peptide drugs

Utilizing Deep Learning Techniques for Improved Classification of GPCR Ligands and Prediction of Metabolites in Drug Development

Discovery of the therapeutic potential of PPARδ agonist bearing 1,3,4- thiadiazole in inflammatory disorders

Converting cold into hot tumor microenvironment by combining immunotherapies

How to quickly and precisely find lead candidate in NCE discovery

Discovery of natural products for the treatment of vitiligo and elucidation of effective substances and mechanisms

Traditional medicine research in the generative AI era

Research on herbal medicine-based tumor immunotherapy targeting immune checkpoints

Current status, trends and next-generation botanical drug.

Discovery of functional substances to promote child growth based on traditional knowledge

Chaperone-mediated autophagy regulates hepatic lipid metabolism through NCoR1 and sortilin degradation: Implications for fatty liver disease

scRNAseq and Its application in vascular biology: Endothelial migration and differentiation

Tumor dormancy and relapse, and the systemic response

Glycine homeostasis requires reverse SHMT flux

Leveraging CROs for nonclinical development of new modality drugs

Understanding and practical aspects for US regulatory affairs and clinical trials in early phase drug development

Regulatory affairs' role and trend in pharmaceutical industry

Panel discussion: Recent trends in CRDMO and collaborative relationships with pharmaceutical industry

Rivoceranib plus Camrelizumab as first-line therapy for unresectable hepatocellular carcinoma

YH32367, a clinical stage Her2/4-1BB bispecific antibody for Her2-expressing solid cancers

Phase 1 trial safety and efficacy of Ragistomig, a bispecific antibody targeting PD-L1 and 4-1BB in advanced solid tumors. (NCT04762641)

Phase 1 trial of TU2218, TGFβ-RI and VEGF-R2 dual inhibitor in monotherapy and combination with pembrolizumab in patients with advanced solid tumors

AI-driven breakthroughs at ASCO2024

Brazilian biodiversity as source of bioactive compounds with therapeutic potential

Acylated triterpene saponins from Asteraceae family

Discovery of antiproliferative metabolites through the induction of silent biosynthetic gene clusters

NMR/MS-based metabolomics analysis of wheat bran chemicals

Current status of my health data policy in South Korea

Policy implications from PHR experiences in other countries

Personal health record and drug utilization research

Application of personal health records in enhancing pharmaceutical care: a narrative review of pharmacists' roles

Introduction of KFRM-supported R&D project

Human pluripotent stem cell-derived myogenic progenitors undergo maturation to quiescent satellite cells upon engraftment

Human pluripotent stem cell-based therapies for Parkinson's disease: challenges and potential Solutions

Precise gene editing in human pluripotent stem cells for ex vivo stem cell therapy

Genomic instability of human iPSCs and challenges towards their clinical applications

Multiomics-based target identification and relapse prevention in incurable diseases

Clinical applications of pharmacogenomics: Personalized drug therapy

Pharmacogenomic approaches to optimizing oral anticoagulation therapy

Genetic and epigenetic aging biomarkers and accelerated aging